BI Asset Management Fondsmaeglerselskab’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932K | Buy |
4,259
+2,240
| +111% | +$490K | 0.01% | 499 |
|
|
2025
Q1 | $452K | Sell |
2,019
-1,013
| -33% | -$227K | 0.01% | 580 |
|
|
2024
Q4 | $993K | Sell |
3,032
-1,131
| -27% | -$370K | 0.01% | 515 |
|
|
2024
Q3 | $1.25M | Buy |
4,163
+777
| +23% | +$233K | 0.02% | 353 |
|
|
2024
Q2 | $1.12M | Buy |
3,386
+77
| +2% | +$25.4K | 0.02% | 377 |
|
|
2024
Q1 | $1.31M | Buy |
3,309
+1,348
| +69% | +$533K | 0.02% | 316 |
|
|
2023
Q4 | $691K | Sell |
1,961
-241
| -11% | -$84.9K | 0.01% | 465 |
|
|
2023
Q3 | $826K | Buy |
2,202
+148
| +7% | +$55.5K | 0.02% | 406 |
|
|
2023
Q2 | $786K | Buy |
2,054
+67
| +3% | +$25.6K | 0.02% | 398 |
|
|
2023
Q1 | $688K | Buy |
1,987
+651
| +49% | +$225K | 0.02% | 400 |
|
|
2022
Q4 | $314K | Buy |
+1,336
| New | +$314K | 0.01% | 474 |
|
|
2022
Q3 | – | Sell |
-530
| Closed | -$160K | – | 494 |
|
|
2022
Q2 | $160K | Buy |
+530
| New | +$160K | 0.01% | 429 |
|
|
2020
Q4 | – | Sell |
-3,972
| Closed | -$1.09M | – | 497 |
|
|
2020
Q3 | $1.09M | Buy |
3,972
+1,794
| +82% | +$493K | 0.05% | 271 |
|
|
2020
Q2 | $495K | Buy |
+2,178
| New | +$495K | 0.03% | 348 |
|
|
2020
Q1 | – | Sell |
-11,649
| Closed | -$1.75M | – | 391 |
|
|
2019
Q4 | $1.75M | Sell |
11,649
-7,905
| -40% | -$1.19M | 0.08% | 208 |
|
|
2019
Q3 | $2.77M | Buy |
+19,554
| New | +$2.77M | 0.14% | 136 |
|